Future Table of Contents


Future Table of Contents

Volume 25, Number 6 (December 2018)

Survival of Patients with Subglottic Squamous Cell Carcinoma
S.D. MacNeil

Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients
F. Cavagna, A. Pontes, M. Cavagna, A.Dzik, N. Donadio, R. Portela, M. T. Nagai, L. H. Gebrim

Patient reported outcome measurement compared to professional judgment of cosmetic results after breast-conserving therapy.
A. Brands-Appeldoorn

A Little Help from My Friends: Social Support in Palliative Rehabilitation
N. A. Rutkowski

Hypertension as a predictor of advanced colorectal cancer outcome and Cetuximab treatment response
S. Sud, C. O'Callaghan, C. Jonker, D. Tu, R. Goodwin

Establishing a Medical Oncology Community of Practice to Improve Cancer Care
W. Fingrut, L. Beck, D. Lo

Medical Oncology Communities of Practice: Insights from a Qualitative Analysis
W. Fingrut, L. Beck, D. Lo

Impact of High-Fidelity eLearning on Knowledge Acquisition in Radiation Oncology Trainees
C. Gillan, J. Papadakos, J. Brual, N. Harnett, A. Hogan, E. Milne, M. E. Giuliani

Does presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?
G. Kasymjanova, R. T. Jagoe, C. Pepe, L. Sakr, V. Cohen, T. M. Muanza, J.S. Agulnik

Impact of Adjuvant Treatment in the Elderly Population with Locally Advanced Rectal Cancer: A Population-Based Retrospective Study
S. L. Liu, P. O’Brien, Y. Zhao, W. M. Hopman, N. Lamond, R. Ramjeesingh

Utilization of targeted therapy in metastatic renal cell carcinoma patients: clinical and economic impact in Canadian real-life setting
S. Nazha, S. Tanguay, A. Kapoor, M. Jewett, C. Kollmansberger, L. Wood, G. Bjarnason, H. Daniel, S. Daniel, N. Reaume, N. Basappa, E. Lévesque, A. Dragomir

Anti-Yo Antibody mediated Paraneoplastic Cerebellar Degeneration associated with Cognitive Affective Syndrome in a patient with breast cancer: a case report and literature review
M. Le May, S. Dent

Reducing the exudate fluid of breast cancer with San Huang decoction by ameliorating inflammatory status: a prospective clinical trial
Z. Zhu, J. Xue, L. Yu, W. Bian, Y. Zhang, K. C. Sohn, I. H. Shin, C. Yao

The Prostate Cancer Rehabilitation Clinic: a bio-psychosocial clinic for sexual dysfunction after radical prostatectomy
A. G. Matthew, N. Lutzky-Cohen, L. Jamnicky, K. Currie, A. Gentile, D. Santa Mina, N. Fleshner, A. Finelli, R. Hamilton, G. Kulkarni, M. A. S. Jewett, A. Zlotta, J. Trachtenberg, Z. Yang, D, Elterman

Appropriate treatment receipt following breast conserving surgery in early stage breast cancer
K. Guidolin

Multiple remissions of extracavitary primary effusion lymphoma treated by a single cycle of liposomal doxorubicin in an HIV-infected patient
J. P. Routy

Moving Research into Practice: Summary Report of the Ex/Cancer Meeting on Physical Activity, Exercise, and Rehabilitation in Oncology
D. Santa Mina, A. Fong, A. R. Gentile, N. S. Culos-Reed, M Chasen, C. M. Sabiston

Contralateral prophylactic mastectomy in young women with breast cancer: a population based analysis of predictive factors and clinical impact.
A. Bouchard-Fortier

Incidence of Spinal Disease and Role of Spinal Radiotherapy in Multiple Myeloma
N. Ahmed

Outcomes by treatment modality in elderly with localized gastric and esophageal cancers.
A. Natori, B. Chan, H. W. Sim, L. Ma, D. W. Yokom, E. Chen, G. Liu, G. Darling, C. Swallow, S. Brar, J. Brierley, J. Ringash, R. Wong, J. Kim, P. Rogalla, S. Hafezi-Bakhtiari, J. Conner, J. Knox, E. Elimova, R. Jang

Upcoming in Current Oncology

Real-world treatment patterns of squamous cell carcinoma of the head and neck in Canada
K. Byrne, P. Hallworth, A. Abbas Tahami Monfared, A. Moshyk, J.W. Shaw

Total pancreatectomy versus partial pancreatectomy for pancreatic adenocarcinoma: Assessment of resection margin, readmission rate, and survival from the National Cancer Database
M. J. Passeri, E. H. Baker, I. A. Siddiqui, M. A. Templin, J.B. Martinie, D. Vrochides, D. A. Iannitti

Risk-reducing interventions in women with a BRCA deleterious mutation: A population-based study in British Columbia, Canada
G. E. Hanley

Second-line Systemic Therapies for Metastatic Urothelial Carcinoma: A Population-Based Cohort Analysis
E. S. Tsang

Perspectives on the Treatment Advances for Stage III Locally Advanced, Unresectable NSCLC
P. K. Cheema, J. Rothenstein, B. Melosky, A. Brade, V. Hirsh

Canadian Consensus: Oligoprogressive, Pseudoprogressive and Oligometastatic NSCLC
S. A. Laurie, S. Banerji. N. Blais, S. Brule, P. K. Cheema, P. Cheung, N. Daaboul, D. Hao, V. Hirsh, R. Juergens, J. Laskin, N. Leighl, R. MacRae, G. Nicholas, D. Roberge, J. Rothenstein, D. J. Stewart, M. S. Tsao

Effects of Magnanimous Therapy on coping, adjustment and living function to advanced lung cancer
X. Huang, A. Yan, Q. Liu, L. Wu

A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma
C. Sakaguchi, K. Ashida, S. Yano, K. Ohe, N. Wada, N. Hasuzawa, Y. Matsuda, S. Sakamoto, R. Sakamoto, H. Uchi, M. Furue, M. Nomura, Y. Ogawa

Optimizing Well Breast Cancer Follow-up Care from the Patient's Perspective
J. Y. Y. Kwan, J. Croke, T. Panzarella, K. Ubhi, A.Fyles, A.Koch, R.Dinniwell, W.Levin, D. McCready, C. Chung, F. Liu, J. Bender

Prognostic values of inflammation-based markers in advanced or metastatic neuroendocrine tumors
Z. Lu

Diabetes mellitus secondary to treatment with immune checkpoint inhibitors
V. Venetsanaki, A. Boutis, A. Chrisoulidou, P. Papakotoulas

Factors associated with receipt of symptom screening in the year following diagnosis in a universal healthcare system: a retrospective cohort study
A. L Mahar, L. E. Davis, L. D. Bubis, Q. Li, R. Sutradhar, N. G. Coburn, L. Barbera

Metabolic tumor volume is prognostic of local control and overall survival in patients with non-small cell lung cancer treated with stereotactic ablative radiotherapy
M. Dosani

A Position Statement on Redefining and Standardizing an Oncoplastic Approach to Breast Conserving Surgery in Canada
A. Arnaout

Factors influencing Radiation Therapists’ use of cancer symptom guides: a mixed methods study
D. Stacey

Efficacy and safety of combined androgen blockade with anti-androgen for advanced prostate cancer
Y. Yang, R. Chen, L. Zhao, F. Liu, S. Ren, H. Wang, X. Lu, X. Gao, C. Xu, Y. Sun

Developing a Patient Group Pathway Model to Accessing Cancer Clinical Trials in Canada
G. Batist, S. Michaud, D. P. Richards, F. Servidio-Italiano, B. D. Stein

Efficacy of second Line Chemotherapy following first Line triplet in patients with metastatic colorectal cancer
S. Bazarbashi, A. Hakoun, A. Gad, M. Elshenawy, A. Aljubran, A. Alzahrani, A. Eldali

A Canadian perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer
S. Dent, C. Ammendolea, S. Edwards, D. Incekol, B. Poirier, A. Christofides, B. Pourmirza, S. Kfoury

Surgical Attitudes Toward Preoperative Breast Magnetic Resonance Imaging (MRI) in Women with Early Stage Breast Cancer (ESBC)
S. D. Mukherjee, N. Hodgson, P. J. Lovrics, K. Dhamanaskar, S. Chambers, J. Sussman

Upfront Stereotactic Radiosurgery in Patients with ≥5 Brain Metastases
E. Hamel-Perreault

Area-level income disparities in colorectal screening in Canada: Evidence to inform future surveillance
A. M.S. Blair, L. Gauvin, S. Ouédraogo, G. D. Datta

Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the Choosing Wisely Canada recommendations
M. Tesch, K. Laing

Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review
M. Laureano, M. Ebraheem, M. Crowther

Ferocious Beast
N. A. Rutkowski

Canadian Perspectives: Update on Inhibition of ALK-positive Tumours in Advanced NSCLC
B. Melosky

Secondary Polycythemia in a Sarcoma Patient: a commentary about cediranib
A. Awan, T. Alcindor

A network approach to developing immuno-oncology combinations in Canada
V. Higenell, R. Fajzel, G. Batist, P. K. Cheema, H. L. McArthur, B. Melosky, D. Morris, T. M. Petrella, R. Sangha, Marie-France Savard, Srikala S Sridhar, John Stagg, David J Stewart, Sunil Verma

Conditional Approval of Cancer Drugs in Canada: Accountability and Impact on Public Funding
S. K. Andersen, N. Penner, A. Chambers, M. E Trudeau, K. Chan, M. C. Cheung

Patient indications for Mohs micrographic surgery: a clinical practice guideline
C. Murray, D. Sivajohanathan, T. P. Hanna, S. Bradshaw, N. Solish, B. Moran, R. Hekkenberg, A. C. Wei, T. Petrella

Advanced Cancer Patients: When, Why, and How to refer to Palliative Care Services
G. Chaput